SCHEMBL122306

SCHEMBL122306

OCC(O)COCc1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CA1 P00915 5/20 0.70
CA2 P00918 3/20 0.70
CA7 P43166 3/20 0.70
CA9 Q16790 3/20 0.70
MAPK1 P28482 1/20 0.55
TSHR P16473 2/20 0.54
CA4 P22748 1/20 0.51
POLB P06746 1/20 0.50
PRMT5 O14744 1/20 0.50
WDR77 Q9BQA1 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2D6 P10635 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
AGER Q15109 1/20 0.50
TACR1 P25103 2/20 0.49
KMT2A Q03164 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL218661 1.00 CA1 (0.70) CA1CA2CA7CA9MAPK1
SCHEMBL16269805 1.00 CA1 (0.70) CA1CA2CA7CA9MAPK1
SCHEMBL508126 1.00 CA1 (0.70) CA1CA2CA7CA9MAPK1
Bicarbonate SCHEMBL17044691 0.94 CA1 (0.64) CA1CA2CA7CA9MAPK1
SCHEMBL397022 0.90 CA1 (0.78) CA1CA2CA7CA9MAPK1
SCHEMBL25300063 0.89 CA1 (0.57) CA1CA2CA7CA9MAPK1
SCHEMBL30590458 0.89 CA1 (0.57) CA1CA2CA7CA9MAPK1
SCHEMBL24207966 0.89 CA1 (0.57) CA1CA2CA7CA9MAPK1
Glycerin SCHEMBL3807616 0.88 TSHR (0.65) CA1CA2CA7CA9MAPK1
SCHEMBL23455700 0.86 CA1 (0.54) CA1CA2CA7CA9MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1291 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260041095-A1 A PRESERVATION METHOD ANALYTICON DISCOVERY ZWEIGNIEDERLASSUNG DER BRAIN BIOTECH AG (DE) 2026-02-12 US claimed
US-20260034044-A1 A PRESERVATIVE COMPOSITION ANALYTICON DISCOVERY ZWEIGNIEDERLASSUNG DER BRAIN BIOTECH AG (DE) 2026-02-05 US claimed
US-12396941-B2 Cosmetic composition that resists pilling L'OREAL (FR) 2025-08-26 US claimed
EP-4565196-A1 A PRESERVATIVE COMPOSITION AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4565065-A1 A PRESERVATION METHOD AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
EP-4565197-A1 A PRESERVATIVE COMPOSITION AnalytiCon Discovery - Zweigniederlassung der BRAIN Biotech AG (DE) 2025-06-11 EP claimed
US-12303576-B2 Two phase water-based smudge-resistant make-up remover L'OREAL (FR) 2025-05-20 US claimed
EP-4450128-A2 ANTIMICROBIAL COMPOSITIONS Symrise AG (DE) 2024-10-23 EP claimed
CN-112996489-B Sol-gel composition 株式会社爱茉莉太平洋 2024-08-02 CN claimed
US-11998633-B2 Topical sol-gel composition for the treatment of dermatitis AMOREPACIFIC CORPORATION (KR) 2024-06-04 US claimed
CN-1110541-C Concentrated water-dispersible stable fiber softener compositions PROCTER & GAMBLE (US) 2003-06-04 CN claimed
US-20030066141-A1 Hair dye compositions KAO CORPORATION (JP) 2003-04-10 US claimed
EP-1238649-A2 Hair dye compositions Kao Corporation (JP) 2002-09-11 EP claimed
US-6248314-B1 Hair dye composition having a particular buffer capacity and containing an alkylene carbonate KAO CORPORATION (JP) 2001-06-19 US claimed
US-6206935-B1 APPLYING BLEACHING AGENTS AND DIRECT DYE KAO CORPORATION (JP) 2001-03-27 US claimed
EP-1022014-A1 Hair dye composition Kao Corporation (JP) 2000-07-26 EP claimed
CN-1219953-A Fabric softening compound/composition PROCTER & GAMBLE (US) 1999-06-16 CN claimed
CN-1196081-A Concentrated, water dispersible, stable, fabric softening compositions PROCTER & GAMBLE (US) 1998-10-14 CN claimed
CN-1195369-A Concentrated and stable fabric softening compositions PROCTER & GAMBLE (US) 1998-10-07 CN claimed
US-5118448-A Process for producing esterified alkoxylated polyols ARCO CHEMICAL TECHNOLOGY, L.P. (US) 1992-06-02 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260041095-A1 A PRESERVATION METHOD LSS, ASAH2, CUTA CA1 512/4885CA2 1066/4885CA7 543/4885
US-20260034044-A1 A PRESERVATIVE COMPOSITION ERG28, FOXO3, DEGS1 CA1 1109/4885CA2 1326/4885CA7 2118/4885
US-20030066141-A1 Hair dye compositions HAAO, SRD5A1, GLA CA1 932/4885CA2 989/4885CA7 48/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.